DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Information source: Astellas Pharma Inc
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Post-operative Peripheral Neuropathic Pain

Intervention: Qutenza (Drug)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Astellas Pharma s.r.o.

Official(s) and/or principal investigator(s):
Medical and Scientific Affairs manager, Study Director, Affiliation: Astellas Pharma s.r.o.

Summary

The aim of this study is to monitor the effectiveness and used dosage of the 8% capsaicin patch in real-life clinical practice in the treatment of post-operative neuropathic pain.

Clinical Details

Official title: A Non-interventional Post-registration Clinical Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Percentage rate of responders

Secondary outcome:

Basic demographic parameters

Previous treatment of neuropathy

Reason for a change in the therapy

Dose

Size of the area affected by neuropathic pain

Concomitant neuropathic medication

Efficacy of treatment

Quality of life questionnaire (EQ-5D)

Consumption of rescue analgesic medication

Consumption of additional medical care for neuropathic pain

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- diagnosed peripheral post-operative neuropathic pain

Exclusion Criteria:

- hypersensitivity to capsaicin

- pregnancy

- diabetes mellitus

- treatment of face

Locations and Contacts

Site: 19 Hospital, Benešov 256 01, Czech Republic

Site: 26 Hospital, Beroun 266 01, Czech Republic

Site: 1 Sv. Anna Hospital, Brno 626 00, Czech Republic

Site: 8 Onco Clinic, Brno 616 00, Czech Republic

Site: 15 Hospital, Havlíčkův Brod 580 02, Czech Republic

Site: 29 Hospital, Hořovice 268 01, Czech Republic

Site: 9 University Hospital, Hradec Králové 500 02, Czech Republic

Site: 4 Hospital, Jihlava 586 02, Czech Republic

Site: 22 Hospital, Karlovy Vary 360 02, Czech Republic

Site: 17 Hospital, Klatovy 339 00, Czech Republic

Site: 25 Private Office, Krnov 794 01, Czech Republic

Site: 16 Hospital, Liberec 460 01, Czech Republic

Site: 23 Hospital, Mladá Boleslav 293 01, Czech Republic

Site: 20 Hospital, Nové Město 549 01, Czech Republic

Site: 10 University Hospital, Olomouc 770 00, Czech Republic

Site: 12 Hospital, Opava 746 00, Czech Republic

Site: 2 University Hospital, Ostrava 701 00, Czech Republic

Site: 6 University Hospital, Plzeň 320 00, Czech Republic

Site: 13 Hospital, Prague 4 141 00, Czech Republic

Site: 18 Rheumatological Institute, Prague 4 141 01, Czech Republic

Site: 5 University Hospital, Prague 5 152 00, Czech Republic

Site: 21 Military Hospital, Prague 6 161 00, Czech Republic

Site: 27 Hospital, Semily 513 01, Czech Republic

Site: 11 Hospital, Sokolov 356 00, Czech Republic

Site: 24 Hospital, Teplice 415 00, Czech Republic

Site: 28 Hospital, Uherské Hradiště 686 02, Czech Republic

Site: 14 Private Office, Vysoké Mýto 566 01, Czech Republic

Site: 3 Bata Hospital, Zlin 760 01, Czech Republic

Site: 7 Private Office, České Budějovice 370 03, Czech Republic

Additional Information

Starting date: January 2014
Last updated: July 27, 2015

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017